Yerushalmi R - Search Results

1

Metastatic behavior of breast cancer subtypes.

Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K. Kennecke H, et al. Among authors: yerushalmi r. J Clin Oncol. 2010 Jul 10;28(20):3271-7. doi: 10.1200/JCO.2009.25.9820. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498394

2

Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation.

Nieto Y, Cagnoni PJ, Nawaz S, Shpall EJ, Yerushalmi R, Cook B, Russell P, McDermit J, Murphy J, Bearman SI, Jones RB. Nieto Y, et al. Among authors: yerushalmi r. J Clin Oncol. 2000 May;18(10):2070-80. doi: 10.1200/JCO.2000.18.10.2070. J Clin Oncol. 2000. PMID: 10811672

3

Chemotherapy for oestrogen-receptor-negative breast cancer.

Yerushalmi R, Gelmon K. Yerushalmi R, et al. Lancet. 2008 Jan 5;371(9606):4-5. doi: 10.1016/S0140-6736(08)60043-4. Lancet. 2008. PMID: 18177755 No abstract available.

4

Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence.

Yerushalmi R, Kennecke H, Woods R, Olivotto IA, Speers C, Gelmon KA. Yerushalmi R, et al. Breast Cancer Res Treat. 2009 Sep;117(2):365-70. doi: 10.1007/s10549-008-0265-1. Epub 2008 Dec 11. Breast Cancer Res Treat. 2009. PMID: 19082705

5

Decline in pulmonary function in patients with breast cancer receiving dose-dense chemotherapy: a prospective study.

Yerushalmi R, Kramer MR, Rizel S, Sulkes A, Gelmon K, Granot T, Neiman V, Stemmer SM. Yerushalmi R, et al. Ann Oncol. 2009 Mar;20(3):437-40. doi: 10.1093/annonc/mdn652. Epub 2009 Jan 12. Ann Oncol. 2009. PMID: 19139179 Free article.

6

Breast carcinoma--rare types: review of the literature.

Yerushalmi R, Hayes MM, Gelmon KA. Yerushalmi R, et al. Ann Oncol. 2009 Nov;20(11):1763-70. doi: 10.1093/annonc/mdp245. Epub 2009 Jul 14. Ann Oncol. 2009. PMID: 19602565 Free article. Review.

7

A phase II trial of a neoadjuvant platinum regimen for locally advanced breast cancer: pathologic response, long-term follow-up, and correlation with biomarkers.

Yerushalmi R, Hayes MM, Gelmon KA, Chia S, Bajdik C, Norris B, Speers C, Hassell P, O'Reilly SE, Allan S, Shenkier TN. Yerushalmi R, et al. Clin Breast Cancer. 2009 Aug;9(3):166-72. doi: 10.3816/CBC.2009.n.027. Clin Breast Cancer. 2009. PMID: 19661040 Clinical Trial.

8

Patterns of relapse in breast cancer: changes over time.

Yerushalmi R, Woods R, Kennecke H, Speers C, Knowling M, Gelmon K. Yerushalmi R, et al. Breast Cancer Res Treat. 2010 Apr;120(3):753-9. doi: 10.1007/s10549-009-0510-2. Epub 2009 Aug 22. Breast Cancer Res Treat. 2010. PMID: 19701704

9

Ki67 in breast cancer: prognostic and predictive potential.

Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA. Yerushalmi R, et al. Lancet Oncol. 2010 Feb;11(2):174-83. doi: 10.1016/S1470-2045(09)70262-1. Lancet Oncol. 2010. PMID: 20152769 Review.

10

Treatment beyond progression: is it moving from belief to evidence?

Yerushalmi R, Gelmon K. Yerushalmi R, et al. Oncologist. 2010;15(8):796-8. doi: 10.1634/theoncologist.2010-0137. Epub 2010 Jul 29. Oncologist. 2010. PMID: 20671106 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page